IBIO vs REGN: Which Stock is Better?
Side-by-side comparison of Ibio Inc and Regeneron Pharmaceuticals Inc in 2026
IBIO
Ibio Inc
$2.06
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | IBIO | REGN | Winner |
|---|---|---|---|
| Market Cap | $72.89M | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.1% | 0.0% | IBIO |
| Gross Margin | 100.0% | 44.6% | IBIO |
Analyze IBIO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBIO or REGN a better investment?
Comparing IBIO and REGN: Ibio Inc has a market cap of $72.89M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBIO and REGN?
IBIO (Ibio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBIO or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBIO or REGN?
IBIO has higher revenue growth at 0.1% vs 0.0% for REGN.
Which company is more profitable: IBIO or REGN?
Ibio Inc (IBIO) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: IBIO or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $72.89M for IBIO.
Should I buy IBIO or REGN in 2026?
Both IBIO and REGN have investment merit. IBIO trades at $2.06 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBIO and REGN stock?
Key differences: Market Cap ($72.89M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.1% vs 0.0%), Gross Margin (100.0% vs 44.6%).